MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202627075619 A) filed by Velavigo Bio, Inc. on June 18, 2026, for Binding Molecule And Antibody-Drug Conjugate And Use Thereof.
Inventors include Wang, Wei; Li, Jing; Ma, Lin; Xu, Man; and Yin, Qun.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Provided are an immunoglobulin single variable domain (ISVD) that specifically binds to EGFR and/or cMet, and an EGFR and/or cMet binding molecule comprising the immunoglobulin single variable domain and an antibody-drug conjugate (ADC). Further provided are a nucleic acid encoding the ISVD or binding molecule, a vector comprising the nucleic acid, and the therapeutic use of the ISVD or binding molecule and the ADC.
Disclaimer: Curated by HT Syndication.
